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Background: Many women die from complications related to pregnancy and childbirth. In developing countries
particularly in sub-Saharan Africa and Asia, where access to emergency obstetrical care is often limited, obstetric
fistula usually occurs as a result of prolonged obstructed labour. Obstetric fistula patients have many social and health
related problems like urinary tract infections (UTIs). Despite this reality there was limited data on prevalence UTIs on
those patients in Ethiopia. Therefore, the aim of this study was to determine the prevalence, drug susceptibility pattern
and associated risk factors of UTI among obstetric fistula patients at Gondar University Hospital, Northwest Ethiopia.
Methods: A cross sectional study was conducted from January to May, 2013 at Gondar University Hospital. From each
post repair obstetric fistula patients, socio-demographic and UTIs associated risk factors were collected by using a
structured questionnaire. After the removal of their catheters, the mid-stream urine was collected and cultured
on CLED. After overnight incubation, significant bacteriuria was sub-cultured on Blood Agar Plate (BAP) and
MacConkey (MAC). The bacterial species were identified by series of biochemical tests. Antibiotic susceptibility
test was done by disc diffusion method. Data was entered and analyzed by using SPSS version 20.
Results: A total of 53 post repair obstetric fistula patients were included for the determination of bacterial isolate
and 28 (52.8%) of them had significant bacteriuria. Majority of the bacterial isolates, 26 (92.9%), were gram
negative bacteria and the predominant ones were Citrobacter 13 (24.5%) and E. coli 6 (11.3%). Enterobacter, E.coli
and Proteus mirabilis were 100% resistant to tetracycline. Enterobacter, Proteus mirabilis, Klebsella pneumonia,
Klebsella ozenae and Staphylococcus aureus were also 100% resistant to ceftriaxone.
Conclusion: The prevalence of bacterial isolates in obstetric fistula patients was high and majority of the isolates
were gram negative bacteria. Even thought the predominant bacterial isolates were Citrobacter and E. coli, all of the
bacterial isolates had multiple antibiotic resistance patterns which alert health profession to look better treatment for
these patients.
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Globally, more than half a million young women die
from complications of pregnancy and childbirth in each
year and almost all these deaths occur in developing
countries [1]. In resource-poor settings, where access to
emergency obstetrical care is often limited, obstetric* Correspondence: yitayihlab@gmail.com
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distribution, and reproduction in any mediumfistula (OF) usually occurs as a result of prolonged
obstructed labour especially in adolescent girls. In parts
of sub-Saharan Africa and Asia, it is estimated that more
than 2 million young women live with untreated obstet-
ric fistula and between 50, 000 and 100, 000 new women
are affected each year [2]. However, many women are
still unaware of the availability of treatment and 80% of
them never seek treatment due to lack of knowledge [3].
Patients with obstetric fistula can have frequent blad-
der infections, incontinence of urine and stool. Manyentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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several years. This may further predispose them to
health related problems like urinary tract infections
(UTI) [3,4]. Urinary tract infection is one of the most
common infectious diseases and it is a serious ailment
in human due to the frequency, recurrence and diffi-
culty in eradication [5,6].
After surgical procedures, catheterization is common
in most obstetric fistula patients to empty the bladder [7].
This post repaired catheterization may provide an oppor-
tunity for the adequate tensile strength and wound healing
[8]. However, the post-repair urethral catheterization may
be associated with increased risk of healthcare-associated
infection in obstetric fistula patients [9]. In addition, these
obstetric fistula patients may also develop several com-
plications such as urethral bleeding, urethritis, urethral
stricture, bladder stones and urinary tract infections
[10,11]. In general, obstetric fistula treatment needs
prolonged hospitalization and more intensive nursing
cares like prolonged bladder catheterization which may
contribute for the development of urinary tract infec-
tions in women who have OF [12]. In Ethiopia, it is esti-
mated that 9 000 women annually develop a fistula [13].
However, little is known about the impact of UTI on
obstetric fistula patients in the country. Data on the
current distribution and antimicrobial drug susceptibil-
ity patterns among urinary bacterial isolates from such
patients in the study area is also scarce. Therefore, the
aim of this study was to determine the prevalence, anti-
microbial susceptibility and UTI associated risk factors
among obstetric fistula patients at Gondar University
Hospital, Northwest Ethiopia.
Methods
Study design, area and period
A cross sectional study was conducted from January to
May 2013 at Gondar University Hospital, Northwest
Ethiopia. Gondar University Hospital is located 738
kilometers far from the capital city, Addis Ababa. This
University Hospital is not only acts as a teaching hos-
pital but also used as a referral hospital for the sur-
rounding regions. The hospital has specializations in
internal medicine, pediatrics, gynecology, surgery, and
other health related specializations and it serves for
greater than five million people in inpatient and out-
patient departments. It has also well organized fistula
clinic that can serve not only for the large community
of Amhara but also for the nearby regions.
Study participants and data collection
The study participants were all post repair fistula patients
who have attended Gondar University Hospital fistula clinic
during the study period. Study participants were inter-
viewed about the presence and duration of their clinicalmanifestation of UTI. Socio-demographic characteristics
and other UTI related risk factors of study participants
were collected using structured questionnaires and the
physical examination was done by a physician working
at fistula clinic.
Collection, handling and transport of urine specimen
After removing their catheters, each post repair fistula
patient was informed by the attending nurses how to
collect a ‘clean-catch’ mid stream urine specimen in the
sterile bottle container. Accordingly, about 10 to 20 ml
urine specimen was collected in a sterile screw-capped,
wide-necked test tube. The specimen was immediately
delivered to the hospital laboratory bacteriology unit for
laboratory analysis.
Culture and identification
After laboratory arrival, the specimen was cultured on
cysteine lactose electrolyte deficient agar (CLED) by
using a calibrated loop that can deliver 0.002 ml of
urine. The streaked culture CLED tube was overnight in-
cubated at 37°C. On the next day, a single colony was
picked from culture plates with significant bacteriuria
(105 colony forming units per ml of urine) and sus-
pended in nutrient broth, and sub cultured onto blood
agar and MacConkey agar and finally incubated at 37°C
for further purification. Pure isolates of bacterial pathogen
was preliminary characterized by colony morphology,
gram-stain, and catalase test. A standard biochemical pro-
cedure was used for full identification of gram- positive
and gram negative bacteria.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests were done on Mueller-
Hinton agar (Oxoid, England) using disk diffusion method
[14]. The antimicrobial agents tested were Ampicillin
(10 μg), Amoxycillin (10 μg), Ceftriaxone (30 μg), Chlor-
amphenicol (30 μg), Ciprofloxacin (5 μg), Gentamycin
(10 μg), Norfluxaciline (10 μg), Cotrimoxazole (25 μg),
Tetracycline (30 μg), Nitrofurantion (300 μg). The drug
susceptibility pattern was interpreted according to Clinical
and Laboratory Standards Institute (CLSI, 2006) (formerly
known as National Committee for Clinical Laboratory
Standards/NCCLS) [15]. Reference strains of E. coli
ATCC 25922 and S. aureus ATCC 25923 were used for
quality control for antimicrobial susceptibility tests [15].
Data analysis procedure
Data were cleaned manually and entered and analyzed
by using SPSS version 20 software. Chi-square test with
95% CI was employed to compare the proportion of bac-
terial isolates with patients’ demographic information and
comparison of antimicrobial resistances. P-value ≤ 0.05
was considered statistically significant.
Table 2 Clinical presentation of obstetric fistula patients





History of suprapubic pain 8 (15.1) 45 (84.9)
History of irritative voiding symptoms 20 (37.7) 33 (62.3)
History of intestinal motility disorders 7 (13.2) 46 (86.8)
History of dysuria 2 (3.8) 51 (96.2)
History of urethral strictures 1 (1.9) 52 (98.1)
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This research project was done after obtaining Institu-
tional Ethical Clearance from the Ethical Committee of
University of Gondar. Informed consent was obtained
from each study participants before collecting socio demo-
graphic data and urine specimens for laboratory analysis.
Results
During the study period, a total of 53 obstetric fistula pa-
tients were attended the clinic and all of them were partici-
pated in the study. The mean age of the study participants
was 28.6 ± 10.8 years with minimum and maximum age of
13 and 65 years respectively. Majority of the study partici-
pants 19 (35.8%) were in the age group of 21-30 years and
44 (83%) were from rural settings. A high proportion 37
(69.8%) of the study participants were married, 42 (79.2%)
were illiterate and 33 (62.3%) were house wives (Table 1).Table 1 Significant bacterial isolate in relation to
socio-demographic characteristics and associated factors







10–20 7 (46.7) 8 (53.3) 15 (28.3)
0.886
21–30 10 (52.6) 9 (47.4) 19 (35.9)
31–40 8 (61.5) 5 (38.5) 13 (24.5)
>40 3 (50.0) 3 (50.0) 6 (11.3)
Residence
Urban 5 (55.6) 4 (44.4) 9 (17.0)
0.857
Rural 25 (56.8) 19 (43.2) 44 (83.0)
Marital status
Single 0 (0.0) 4 (100.0) 4 (7.5)
0.032Married 19 (51.4) 18 (48.6) 37 (69.8)
Divorced 9 (75.0) 3 (25.0) 12 (22.6)
Education
Illiterate 23 (54.8) 19 (45.2) 42 (79.2)
0.582
Primary school 5 (45.5) 6 (54.5) 11 (20.8)
Occupation
Merchant 2 (66.7) 1 (33.3) 3 (5.7)
0.169
Farmer 7 (77.8) 2 (22.2) 9 (17.0)
Student 1 (33.3) 2 (66.7) 3 (5.70
House wife 15 (45.5) 18 (54.5) 33 (62.3)
Daily laborer 2 (40.0) 3 (60.0) 5 (9.4)
Prev. hist. of catheterization
Yes 21 (56.8) 16 (43.2) 37 (69.8)
0.384
No 7 (43.8) 9 (56.2) 16 (30.2)
Key: Prev. hist. of catheterization - Previous history of catheterization before
seeking obstetric fistula treatment center.The overall prevalence of bacterial isolate was 28
(52.8%) and 10 (62.5%) of the isolates were from symp-
tomatic cases. Majority of the bacterial isolates 8 (61.5%)
were in the age groups of 31-40 years (P = 0.886). A high
prevalence of significant bacteriuria was also isolated
from divorced 9 (75.0%) (P = 0.032), illiterate 23 (54.8%)
and farmer 7 (77.8%) study participants. Majority of the
study participants 33 (62.3%) had previous history of
catheterization (Table 1). Eight (15.1%) and 20 (37.7%)
of the obstetric fistula patients had history of supra-
pubic pain and irritative voiding symptoms, respectively.
They had also history of dysuria (3.8%) and urethral
strictures (1.9%) (Table 2).
In this study, majority 26 (92.9%) of the bacterial iso-
lates were gram negative bacteria and the predominant
isolates were Citrobacter 13 (24.5%) and E. coli 6 (11.3%)
(Table 3). E. coli, Enterobacter and Proteus mirabilis
were 100% resistant to TTC. Furthermore, Enterobacter,
Proteus mirabilis, Klebsella pneumonia, Klebsella oze-
nae and Staphylococcus aureus were also 100% resistant
to CRO (Table 4).
Discussion
Though UTI is common in both men and women, there
is a large difference in UTI prevalence between them
due to variety of factors [16]. Obstetric fistula is one of
the risk factors for the development of UTI in women.
But there is a lack of concrete evidences that show the
magnitude of UTI and antimicrobial sensitivity pattern
in obstetric fistula patients throughout the world and itTable 3 Bacterial isolates from obstetric fistula patients
at Gondar University Hospital, Northwest Ethiopia, 2013
Bacterial isolates Frequency Percent
Staphylococcus aureus 2 3.8
Escherchia coli 6 11.3
Citrobacter 13 24.5
Enterobacter 3 5.7
Proteus mirabilis 1 1.9
Klebsella pneumonia 1 1.9
Klebsella ozenae 2 3.8
Table 4 Antimicrobial susceptibility pattern of bacterial isolates from obstetric fistula patients at Gondar University
Hospital, Northwest Ethiopia, 2013
Bacterial isolates Antimicrobial agents
AMP AMX CRO CAF CIP CN NOR SXT TTC
E. coli S 2 (33.3) 3 (50.0) 3 (50.0) 5 (83.3) 3 (50.0) 2 (33.3) 2 (33.3) 2 (33.3) 0 (0.0)
R 4 (66.7) 3 (50.0) 3 (50.0) 1 (16.7) 3 (50.0) 4 (66.7) 4 (66.7) 4 (66.7) 6 (100.0)
Citrobacter S 4 (30.8) 4 (30.8) 7 (53.8) 3 (23.1) 6 (46.2) 5 (38.5) 6 (46.2) 5 (38.5) 5 (38.5)
R 9 (69.2) 9 (69.2) 6 (46.2) 10 (76.9) 7 (53.8) 8 (61.5) 7 (53.8) 8 (61.5) 8 (61.5)
Enterobacter S 2 (66.7) 1 (33.3) 0 (0.0) 0 (0.0) 2 (66.7) 19 (33.3) 2 (66.7) 2 (66.7) 0 (0.0)
R 1 (33.3) 2 (66.7) 3 (100.0) 3 (100.0) 1 (33.3) 2 (66.7) 1 (33.3) 1 (33.3) 3 (100.0)
Proteus mirabilis S 0 (0.0) 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.0)
R 1 (100.0) 1 (100.0) 1 (100.0) 0 (0.0) 1 (100.0) 1 (100.0) 0 (0.0) 1 (100.0) 1 (100.0)
Klebsella pneumonia S 1 (100.0) 0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 1 (100.0) 1 (100.0)
R 0 (0.0) 1 (100.0) 1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 1 (100.0) 0 (0.0) 0 (0.00
Klebsella ozenae S 1 (50.0) 0 (0.0) 0 (0.0) 1 (50.0) 1 (50.0) 1 (50.0) 2 (100.0) 0 (0.0) 1 (50.0)
R 1 (50.0) 2 (100.0) 2 (100.0) 1 (50.0) 1 (50.0) 1 (50.0) 0 (0.0) 2 (100.0) 1 (50.0)
Staphylococcus aureus S 0 (0.0) 0 (0.0) 0 (0.0) 1 (50.0) 0 (0.0) 1 (50.0) 0 (0.0) 0 (0.0) 2 (100.0)
R 2 (100.0) 2 (100.0) 2 (100.0) 1 (50.0) 2 (100.0) 1 (50.0) 2 (100.0) 2 (100.0) 0 (0.0)
Keys: AMP, ampicillin, AMX, amoxacillin, CRO, ceftriaxone, CAF, chloramphenicol, CIP, ciprofloxacin, CN, gentamycin, NOR, norfluxaciline, SXT, co-trimoxazole,
TTC, tetracycline.
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vious reports. In the present study, the overall preva-
lence of UTI was 28 (52.8%) which is almost similar
with other report in Nigeria (76.1%) [17]. But this find-
ing was higher than other studies in Kenya 8.0% [18]
and Nigeria 11 (9.2%) [19]. The prevalence of UTI in
the present study was also higher than another reports
from pregnant women in the study area [20], Addis
Ababa Ethiopia [21] and Tanzania [22]. This difference
in similar study participants may be due to the differ-
ence in the risk factors like history of catheterization
and immune system of the study participants. As indi-
cated in Table 1, majority of the study participants had
previous history of catheterization before seeking ob-
stetric fistula treatment and this factor might increase
the development of UTIs.
In the present study, the prevalence of symptomatic
and asymptomatic bacteriuria were 10 (62.5%) and 18
(48.6%), respectively. Similar findings were also reported
in previous studies in Ethiopia [20] and Tanzania [22]
from pregnant women. In this study, a statically signi-
ficant bacteriuria was found among divorced study par-
ticipants. This might be associated with the study
participant psychological readiness to keep their per-
sonal hygiene. In addition to developing obstetric fis-
tula, divorcing may upset them to be hopeless and they
may not be ready to accept it and developed mental
trauma and they may not bother about their personal
hygiene. Furthermore, they may not know how to keep
their personal hygiene due to lack of knowledge. Butthere is no previous supportive data regarding to these
issues and it needs further studies.
In the present study, the predominant bacterial isolates
were gram negative which was similar to other findings
in the study area [20] and Addis Ababa, Ethiopia [21]
from pregnant women. In this study, the most common
bacterial isolates were Citrobacter and E. coli. A similar
high proportion of E. coli was also reported in Sudan
[23] and Yemen [24] studies. Though E. coli is consid-
ered the most uropathogenic due to its virulence factors
for colonization and invasion of the urinary epithelium
[25], Citrobacter can be also the most important uro-
pathogens in the study area but it needs further study
on its epidemiology and risk factors.
The majority of the bacterial isolates were from rural
settings and illiterate study participants since these study
groups may not have awareness how to keep their per-
sonal hygiene. Similarly, these study participants may
lived for several years with obstetric fistula before treat-
ment and this might increase the development of UTI in
these study groups. However, there is no previous data
regarding to this issue and it needs further study on dif-
ferent settings with a different study design like longitu-
dinal comparative study.
Prescribing and giving antibiotics without testing anti-
biotic resistance pattern in developing countries includ-
ing Ethiopia is a common problem for the development
of drug resistance. In the present study, majority of the
bacterial isolates were highly resistant to tetracycline and
ceftriaxone. A similar finding was also reported in other
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associated with previous exposure of the bacterial iso-
lates to these antibiotics. In addition, in rural settings
including the study area, use of antibiotics without proper
prescription with health professionals is also a common
practice. All these factors may be used as a risk factor for
the development of antibiotic resistance especially for the
commonly used ones. Furthermore, all of the bacterial iso-
lates in this study were multidrug resistant.
Conclusion
In conclusion, the prevalence of bacterial isolates in ob-
stetric fistula patients was high and majority of the isolates
were gram negative bacteria. The predominant bacterial
isolates were Citrobacter and E. coli. All of the bacterial
isolates had multiple antibiotic resistance patterns. There-
fore antibiotic susceptibility test is mandatory before pre-
scribing any antibiotic drugs.
Limitation
Due to the small sample size, it may be difficult to con-
clude the magnitude of UTI problems on obstetric fis-
tula patients. In addition, the clinical presentation and
risk factors such as prolonged catheterization, presence
of urinary retention, urethral instrumentation, poor im-
mune system and concurrent fecal incontinences need
further detailed study with large sample size.
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